Glucotrack, Inc. (GCTK): Shareholders' Equity

Annual figures by period end, from SEC filings.

$2.83M
As of 2025-12-31
-$1.74M
As of 2026-06-30
+32.0%
3-year compound annual growth
-20.6%
5-year compound annual growth
$8.98M2002-12-31: -$22.9K2003-12-31: -$388.2K2004-12-31: -$487.6K2005-12-31: -$270.1K2006-12-31: $1.78M2007-12-31: $542.2K2008-12-31: $49.8K2009-12-31: -$775.7K2010-12-31: $598.1K2011-12-31: $968.2K2012-12-31: -$503.1K2013-12-31: -$11.06M2014-12-31: -$4.83M2015-12-31: -$6.97M2016-12-31: -$10.95M2017-12-31: -$16.57M2018-12-31: -$2.87M2019-12-31: -$1.41M2020-12-31: $8.98M2021-12-31: $5.16M2022-12-31: $1.23M2023-12-31: $3.20M2024-12-31: -$13.00M2025-12-31: $2.83M$2.83M
2002-12-31 Shareholders' Equity (USD) 2025-12-31
Period endedShareholders' EquityChange YoYSource filing
2025-12-31$2.83Mn/m2026-03-30, Balance as of period end
2024-12-31-$13.00Mn/m2026-03-30, Balance as of period end
2023-12-31$3.20M+159.9%2025-03-31, Balance as of period end
2022-12-31$1.23M-76.1%2024-03-28, Balance as of period end
2021-12-31$5.16M-42.6%2023-03-31, Balance as of period end
2020-12-31$8.98Mn/m2022-03-31, Balance as of period end
2019-12-31-$1.41Mn/m2021-04-13, Balance as of period end
2018-12-31-$2.87Mn/m2020-04-14, Balance as of period end
2017-12-31-$16.57Mn/m2019-04-15, Balance as of period end
2016-12-31-$10.95Mn/m2018-03-30, Balance as of period end
2015-12-31-$6.97Mn/m2018-03-30, Balance as of period end
2014-12-31-$4.83Mn/m2017-03-31, Balance as of period end
2013-12-31-$11.06Mn/m2016-03-30, Balance as of period end
2012-12-31-$503.1Kn/m2015-03-31, Balance as of period end
2011-12-31$968.2K+61.9%2014-03-28, Balance as of period end
2010-12-31$598.1Kn/m2014-03-28, Balance as of period end
2009-12-31-$775.7Kn/m2014-03-28, Balance as of period end
2008-12-31$49.8K-90.8%2014-03-28, Balance as of period end
2007-12-31$542.2K-69.5%2014-03-28, Balance as of period end
2006-12-31$1.78Mn/m2014-03-28, Balance as of period end
2005-12-31-$270.1Kn/m2014-03-28, Balance as of period end
2004-12-31-$487.6Kn/m2014-03-28, Balance as of period end
2003-12-31-$388.2Kn/m2014-03-28, Balance as of period end
2002-12-31-$22.9Kn/a2014-03-28, Balance as of period end

Shareholders' Equity at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedShareholders' EquityChange YoY
Glucotrack, Inc. (GCTK)2025-12-31$2.83Mn/m
Autonomix Medical, Inc. (AMIX)2026-03-31$5.89M-27.2%
RenovoRx, Inc. (RNXT)2025-12-31$5.42M+21.1%
Bluejay Diagnostics, Inc. (BJDX)2025-12-31$5.98M+4.3%
Medinotec Inc. (MDNC)2026-02-28$5.71M+33.7%
Sintx Technologies, Inc. (SINT)2025-12-31$2.93M-24.8%
Biotricity Inc. (BTCY)2026-03-31-$34.68Mn/m
Aethlon Medical Inc (AEMD)2026-03-31$4.89M-4.6%
Nexgel, Inc. (NXGL)2025-12-31$4.46M-22.5%

Compare GCTK, AMIX, RNXT, BJDX side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗